Psyence Biomedical (PBMWW) Stock Price, Quote, News & History

Q: What sector and industry does Psyence Biomedical (PBMWW) operate in?

Psyence Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Psyence Biomedical Ltd (PBMWW) Stock Price, Quote, News & History

PBMWWNASDAQ

Trade with Public

At close: Feb 10, 4:00 PM EST

$0.0212

0.00031.44%

After Hours: 9:25 AM EST

Key Statistics

Open

$0.02

Volume / Avg.

27.53K / 35.14K

Day Range

$0.02 - $0.02

52 Wk Range

0.01 - 0.04

Market Cap

$277.08K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

1.14

Recent Psyence Biomedical Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.25M

Investing Cash Flow (TTM)

-4.02M

Financing Cash Flow (TTM)

13.49M

Free Cash Flow (TTM)

-4.25M

Capital Expenditure (TTM)

-3.68K

Net Change in Cash (TTM)

5.22M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$7.15M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.02

Volume / Avg.

27.53K / 35.14K

Day Range

$0.02 - $0.02

52 Wk Range

0.01 - 0.04

Market Cap

$277.08K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

1.14

About

Sector

Health Care

Industry

Biotechnology

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequenc...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Psyence Biomedical (PBMWW) stock?

You can purchase shares of Psyence Biomedical (NASDAQ:PBMWW) through any online brokerage.

View our list of the best stock brokerages

Who are Psyence Biomedical (PBMWW) competitors?

Other companies in Psyence Biomedical’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Ernexa Therapeutics Inc (NASDAQ:ERNAW), Bio Green Med Solution Inc (NASDAQ:BGMSP), Liminatus Pharma Inc (NASDAQ:LIMNW) and Azitra Inc (AMEX:AZTR).

What is the forecast, or price target, for Psyence Biomedical (PBMWW) stock?

There is no analysis for Psyence Biomedical to provide a consensus price target.

What is the current price for Psyence Biomedical (PBMWW)?

The stock price for Psyence Biomedical (NASDAQ: PBMWW) is $0.0212 last updated February 10, 2026 at 9:25 AM EST.

Does Psyence Biomedical (PBMWW) pay a dividend?

There are no upcoming dividends for Psyence Biomedical.

When is Psyence Biomedical (NASDAQ:PBMWW) reporting earnings?

Psyence Biomedical does not have any upcoming earnings scheduled.

Is Psyence Biomedical (PBMWW) going to split?

There is no upcoming split for Psyence Biomedical.

What sector and industry does Psyence Biomedical (PBMWW) operate in?

Psyence Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ernexa Therapeutics Inc

NASDAQ:ERNA

$0.30

1.78%

Ernexa Therapeutics Inc

NASDAQ:ERNAW

-100.00%

Bio Green Med Solution Inc

bioAffinity Technologies Inc

Dermata Therapeutics Inc

NASDAQ:DRMAW

$0.02

38.15%

Key Statistics

Open

$0.02

Volume / Avg.

27.53K / 35.14K

Day Range

$0.02 - $0.02

52 Wk Range

0.01 - 0.04

Market Cap

$277.08K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

1.14

Recent Psyence Biomedical Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.25M

Investing Cash Flow (TTM)

-4.02M

Financing Cash Flow (TTM)

13.49M

Free Cash Flow (TTM)

-4.25M

Capital Expenditure (TTM)

-3.68K

Net Change in Cash (TTM)

5.22M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$7.15M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.02

Volume / Avg.

27.53K / 35.14K

Day Range

$0.02 - $0.02

52 Wk Range

0.01 - 0.04

Market Cap

$277.08K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

1.14

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry